We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
(+12%)
Cap. Flow
+$78.1B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
8.1
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3276
Espey Mfg & Electronics Corp
ESP
$162M
| $4.1M | ﹤0.01% |
89,744
+8,951
| +11% | +$309K |
2017 Q3
31 quarters
|
|
3277
Solesence Inc
SLSN
$62.8M
| $4.1M | ﹤0.01% |
+940,848
| New | +$3.3M |
2025 Q2
0 quarters
|
|
3278
AFC Gamma
AFCG
$69.7M
| $4.1M | ﹤0.01% |
915,142
+10,321
| +1% | +$53.1K |
2021 Q2
16 quarters
|
|
3279
Biglari Holdings Class A
BH.A
$1.29B
| $4.09M | ﹤0.01% |
2,922
+89
| +3% | +$106K |
2018 Q2
28 quarters
|
|
3280
Inovio Pharmaceuticals
INO
$108M
| $4.09M | ﹤0.01% |
2,009,145
-19,815
| -1% | -$38K |
2013 Q2
48 quarters
|
|
3281
Skillsoft
SKIL
$53.3M
| $4.09M | ﹤0.01% |
255,926
+30,077
| +13% | +$569K |
2021 Q3
15 quarters
|
|
3282
America Movil
AMX
$67B
| $4.08M | ﹤0.01% |
227,482
-78,166
| -26% | -$1.3M |
2023 Q3
7 quarters
|
|
3283
Magnachip Semiconductor
MX
$205M
| $4.07M | ﹤0.01% |
1,023,505
-7,540
| -0.7% | -$26.2K |
2020 Q2
20 quarters
|
|
3284
iShares Core MSCI EAFE ETF
IEFA
$190B
| $4.07M | ﹤0.01% |
48,736
+5,359
| +12% | +$425K |
2023 Q1
9 quarters
|
|
3285
Vanguard Information Technology ETF
VGT
$150B
| $4.06M | ﹤0.01% |
48,944
-496
| -1% | -$36.1K |
2023 Q1
9 quarters
|
|
3286
Journey Medical
DERM
$145M
| $4.06M | ﹤0.01% |
564,988
+192,727
| +52% | +$1.33M |
2022 Q2
12 quarters
|
|
3287
Alto Ingredients
ALTO
$284M
| $4.03M | ﹤0.01% |
3,508,312
-42,735
| -1% | -$40.9K |
2013 Q2
48 quarters
|
|
3288
Kyverna Therapeutics
KYTX
$369M
| $4.03M | ﹤0.01% |
1,312,767
+14,318
| +1% | +$35.4K |
2024 Q1
5 quarters
|
|
3289
Bakkt Inc
BKKT
$266M
| $4.01M | ﹤0.01% |
287,460
+30,804
| +12% | +$340K |
2021 Q4
14 quarters
|
|
3290
Caris Life Sciences
CAI
$8.98B
| $4.01M | ﹤0.01% |
+150,000
| New | +$4.04M |
2025 Q2
0 quarters
|
|
3291
Cardlytics
CDLX
$12.1M
| $3.98M | ﹤0.01% |
241,691
-25,122
| -9% | -$434K |
2018 Q1
29 quarters
|
|
3292
DELISTED
AstroNova
ALOT
| $3.97M | ﹤0.01% |
342,598
-6,470
| -2% | -$57.5K |
2013 Q2
48 quarters
|
|
3293
IBEX
IBEX
$610M
| $3.96M | ﹤0.01% |
135,929
+44,399
| +49% | +$1.19M |
2020 Q3
19 quarters
|
|
3294
Filana Therapeutics
FLNA
$36.8M
| $3.93M | ﹤0.01% |
2,170,072
-272,235
| -11% | -$484K |
2013 Q2
48 quarters
|
|
3295
PAMT Corp
PAMT
$250M
| $3.93M | ﹤0.01% |
304,982
-20,321
| -6% | -$273K |
2013 Q2
48 quarters
|
|
3296
Crawford & Co Class A
CRD.A
$591M
| $3.92M | ﹤0.01% |
370,741
+71,191
| +24% | +$757K |
2013 Q2
48 quarters
|
|
3297
Lyell Immunopharma
LYEL
$201M
| $3.91M | ﹤0.01% |
442,626
-44,260
| -9% | -$403K |
2021 Q2
16 quarters
|
|
3298
QuickLogic
QUIK
$171M
| $3.86M | ﹤0.01% |
627,290
-104,555
| -14% | -$574K |
2013 Q2
48 quarters
|
|
3299
1stdibs.com
DIBS
$144M
| $3.85M | ﹤0.01% |
1,399,850
-104,811
| -7% | -$272K |
2021 Q2
16 quarters
|
|
3300
Universal Electronics
UEIC
$66.6M
| $3.84M | ﹤0.01% |
580,813
| – | – |
2013 Q2
48 quarters
|
|
Similar funds
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.